News Flash >

Women's Health

 

Melatonin Modulates the Action of Near Infrared Radiation on Cell Adhesion
(Cervical Cancer-April 29, 2003)


According to published research from Russia, "The adhesion of human cervical cancer (HeLa) cells to a glass matrix is evaluated following their irradiation in a suspension with a pulsed near-infrared (IR) light-emitting diode (wavelength 820 nm, pulse repetition frequency 10 Hz, irradiation dose 16-120 J/m2 ) when melatonin (4 x 10-11 to 4 x 10-5 m) is added to cell suspension immediately before or after the irradiation.

"Also, the dependence of visible-to-near-IR radiation (600-840 nm, 52 J/m2) on cell adhesion (action spectrum) is recorded in absence and presence of melatonin (4 x 10-6 m). It is found that melatonin in pharmacological concentrations (but not in physiological range) inhibited cell adherence," wrote T.I. Karu and colleagues, Russian Academy of Science, Institute of Laser & Information Technology.

"Irradiation of cells before or after melatonin treatment normalizes cell adhesion to control level. Melatonin in pharmacological concentrations eliminates stimulation of cell attachment induced by irradiation. Pretreatment (but not post-treatment) with melatonin in the physiological concentration eliminates cell adhesion stimulation induced by irradiation," the researchers stated.

The researchers concluded: "Melatonin modifies the light action spectrum significantly in near IR region (760-840 nm only). Thus, the peak at 820 - 830 nm characteristic for the light action spectrum is fully reduced."

Karu and colleagues published their findings in the Journal of Pineal Research (Melatonin modulates the action of near infrared radiation on cell adhesion. J Pineal Res, 2003;34(3):167-172).

Additional information can be obtained by contacting T.I. Karu, Russian Academy of Science, Institute of Laser & Information Technology, Pionerskaya Str 2, Troitsk 142190, Moscow Region, Russia.

The information in this article comes under the major subject area of Oncology. This article was prepared by Cancer Weekly editors from staff and other reports.

©Copyright 2003, Cancer Weekly via NewsRx.com & NewsRx.net

This story has been adapted from a news release issued by NewsRx.com & NewsRx.net